1. Prognostic factors of overall and prostate‐specific antigen‐progression‐free survival in metastatic castration‐resistant prostate cancer patients treated with 177Lu‐PSMA‐617. A single‐center prospective observational study. Issue 8 (15th March 2023) Authors: Telli, Tugce; Tuncel, Murat; Karabulut, Erdem; Aksoy, Sercan; Erman, Mustafa; Akdogan, Bulent; Caglar, Meltem Journal: Prostate Issue: Volume 83:Issue 8(2023) Page Start: 792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗